SUMMARY In a preliminary report from the Caerphilly study four haemostatic factors showed univariate associations with prevalent ischaemic heart disease after adjusting for age. These factors were fibrinogen concentration, plasma viscosity, white cell count, and the heparin-thrombin clotting time. Age and these haemostatic variables were entered into a stepwise multiple logistic regression analysis; after age the white cell count and heparin-thrombin clotting time remained significantly associated with ischaemic heart disease. Further regression analyses indicated that diastolic blood pressure contributed additionally to this association with ischaemic heart disease but that smoking habit did not.
Hospital, Portmouth SUMMARY In a preliminary report from the Caerphilly study four haemostatic factors showed univariate associations with prevalent ischaemic heart disease after adjusting for age. These factors were fibrinogen concentration, plasma viscosity, white cell count, and the heparin-thrombin clotting time. Age and these haemostatic variables were entered into a stepwise multiple logistic regression analysis; after age the white cell count and heparin-thrombin clotting time remained significantly associated with ischaemic heart disease. Further regression analyses indicated that diastolic blood pressure contributed additionally to this association with ischaemic heart disease but that smoking habit did not.
Epidemiological studies have indicated that existing risk factors such as plasma cholesterol concentration, smoking habit, and hypertension predict only a modest proportion of new cases of ischaemic heart disease.' Data on possible haemostatic mechanisms in the pathogenesis ofischaemic heart disease are scarce, but two prospective studies have indicated that haemostatic factors may be independently predictive of ischaemic heart disease and stroke respectively.23 A recent postmortem case series of subjects with ischaemic heart disease who had died within six hours. after the onset of chest pain found coronary thrombi present in 74% of cases. 4 No intraluminal thrombi were found in age matched controls.
These reports provide evidence that haemostatic factors may be implicated in the pathogenesis of ischaemic heart disease. Several such factors are being investigated in the Caerphilly prospective study. Preliminary data are available for cases of ischaemic heart disease defined cross sectionally by the use of a standardised questionnaireS and a 12 lead electrocardiogram. These data form the basis of the present report.
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Accepted for publicadon 8 clotting time of 82 s, whereas subjects with a thrombin time of <25 s had a mean heparin-thrombin clotting time of 31 s. Samples from six subjects, two of whom had some evidence of ischaemic heart disease and four of whom did not, were excluded on these grounds. Antithrombin III concentrations were estimated using a chromogenic assay (antithrombin III C)12 and also immunologically (antithrombin III I). 13 A full blood count, which included a white cell and platelet count, was done using a Coulter model S-plus cell counter in whole blood anticoagulated with edetic acid. Cell counts were carried out within four to 10 (mean six) hours after venepuncture and the nephelometric fibrinogen and plasma viscosity usually within 12 hours after collection. The assays on platelet poor plasma (the heparin-thrombin clotting time, thrombin time, and clottable fibrinogen) were carried out after a standard delay overnight of 28 to 32 hours. In hot or warm weather conditions a frozen cooler pack was placed inside the container. Antithrombin III assays were carried out in large batches on platelet poor citrated plasma frozen at -20°C and stored for up to three months.
A 5% sample of duplicate samples was presented "blind" to each laboratory during the course of the study. The coefficients of variation of the duplicate pairs for fibrinogen N and fibrinogen C concentrations, viscosity, white cell count, heparin-thrombin clotting time, platelet count, and antithrombin III C and antithrombin III I concentrations were 7%/o, 11%, 2%, 3%, 24%, 7%o, 11%, and 10%, respectively. A second blood sample was taken from a small group of men (n=8-12) some four to 12 weeks after the initial sample. Coefficients of variation for these pairs of results for fibrinogen N and fibrinogen C concentrations, viscosity, white cell count, and heparin- Subjects were classified as having ischaemic heart disease if one or more of the criteria described above were satisfied. Table 1 shows that 33 subjects (10%) aged 30 to 44 and 58 (29%/6) aged 55-69 had some evidence of ischaemic heart disease classified by the use of epidemiological criteria.
The relation between ischaemic heart disease and the haemostatic variables was examined in a series of detailed analyses. Several of the haemostatic variables were dependent on age, and after age adjustment five of the haemostatic variables showed significant associations with ischaemic heart disease: fibrinogen N concentration (p<O001), fibrinogen C concentration (p<0C0l), viscosity (p<O0O5), white cell count (p<0-001), and heparin-thrombin clotting time (p<0c00l). Two variables (heparin-thrombin clotting time and white cell count) had distributions that were appreciably skewed, and in all analyses these data were transformed to logarithms. Platelet count and the two assays for antithrombin III did not show significant associations with ischaemic heart disease, and most subsequent analyses do not include these variables. Table 2 shows the mean values of the five haemostatic variables that were significantly associated with ischaemic heart disease by age and ischaemic heart disease category. Table 3 shows the correlation matrix for the five haemostatic variables and age. There were highly significant (p<0.001) associations between the haemostatic variables; those between the fibrinogen concentrations and viscosity and between the fibrinogen concentrations and heparin-thrombin clotting time were particularly strong. The associations between age and the haemostatic variables were much less pronounced. There were significant positive associations between fibrinogen concentrations, viscosity, and age. The correlation coefficients between heparin-thrombin clotting time and age and between white cell count and age were both very small.
Age and the five haemostatic variables were then entered into a stepwise multiple logistic regression analysis with prevalent ischaemic heart disease as the dependent variable. Table 4 shows a summary of the results. Age entered the regression model first followed by white cell count and heparin-thrombin clotting time. Neither the fibrinogens nor viscosity added significantly to this basic model. Regression coefficients were standardised by transforming each independent variable to zero mean and unit standard deviation. The regression coefficients for the different variables are thus directly comparable.
Smoking habit was strongly related to many of the haemostatic variables. Table 5 shows that cigarette smokers had a much higher mean white cell count and much lower mean heparin-thrombin clotting time than non-smokers, while exsmokers and cigar and pipe smokers held an intermediate position.
The addition of smoking habit to the basic regression model did not add significantly to the model and did not affect the coefficients for white cell count and heparin-thrombin clotting time in other than a trivial Haemostatic manner. For the purpose of this analysis smoking habit was treated as a factor at six levels ( Table 5) . A similar lack of effect was found when alcohol consumption and obesity (Quetelet's index) were added to the basic model. The addition of diastolic blood pressure significantly improved (x2 = 8-6; p<0-01) the fit of the model but did not alter the association between prevalent ischaemic heart disease and either white cell count or heparin-thrombin clotting time. Table 6 shows the values of the standardised regression coefficients obtained. This work was supported by a gant from the British Heart Foundation.
